AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17568867
Drug: Amoxicillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (500 mg every eight hours for ten days, n = 53)
Trial: 9813870
Drug: Oral Mg
RxNorm normalized name: cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Mg supplementation (500 mg Mg-oxide.d-1 for 3 weeks)
Trial: 7710435
Drug: Treatment A
RxNorm normalized name: Nix Ultra Lice Treatment And Prevention Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment A (20 mg isosorbide-5-mononitrate, oral)
Trial: 7710435
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B (20 mg isosorbide-5-mononitrate, oral)
Trial: 7710435
Drug: Treatment C
RxNorm normalized name: Acne Treatment Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C (20 mg isosorbide-5-mononitrate, intravenous)
Trial: 30473139
Drug: Spironolactone 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 12.5 mg daily
Trial: 27646835
Drug: sacubitril/valsartan 97/103
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sacubitril/valsartan 97/103 mg two times daily
Trial: 27646835
Drug: irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: irbesartan 300 mg one time daily
Trial: 23642942
Drug: Panax notoginseng
RxNorm normalized name: PANAX NOTOGINSENG TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panax notoginseng 4000 mg capsules
Trial: 21942957
Drug: If channel
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: If channel inhibitor ivabradine (12.1±2.3 mg/day)
Trial: 21942957
Drug: Slow release
RxNorm normalized name: Slow Release Iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow release metoprolol succinate (59.1±4.5 mg/day)
Trial: 31493104
Drug: TRUS-PNB group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRUS-PNB group receiving 60 mg lidocaine gel intrarectally and infiltration of a prilocaine and bupivacaine mixture (5 mL of 2% prilocaine + 5 mL of 0.25% bupivacaine).
Trial: 25213774
Drug: AMG 811
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 811 (180 mg SC)
Trial: 18830192
Drug: IV infusion
RxNorm normalized name: IV INFUSION SET (WINTHROP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV infusion of 2 g of magnesium sulfate
Trial: 14764128
Drug: Duloxetine 40
RxNorm normalized name: duloxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 40 mg twice daily for 12 weeks
Trial: 9151061
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no drug regimen specified)
Trial: 8423888
Drug: Bromocriptine (Br)
DrugBank: Bromocriptine (DB01200)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromocriptine (Br) monotherapy
Trial: 8423888
Drug: Levodopa (LD)
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa (LD) monotherapy
Trial: 8423888
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Br and LD)
Trial: 19400981
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (duration: 4 weeks)
Trial: 19400981
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (1-2 weeks)
Trial: 7761011
Drug: Peridural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peridural morphine hydrochloride (0.5 mg/kg)
Trial: 3051332
Drug: Glycosaminoglycan polysulphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycosaminoglycan polysulphate (GAGPS) treatment
Trial: 25989216
Drug: Mangiferin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mangiferin (150 mg/day)
Trial: 18638711
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine therapy (WM) including voltaren extended action tablet, methotrexate, and sulfasalazine
Trial: 18638711
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine therapy (CM) including Glucosidorum Tripterygll Totorum tablet and Yishen Juanbi Tablet
Trial: 18638711
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine therapy (CM)
Trial: 16122909
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment (IT)
Trial: 15072604
Drug: Bicalutamide as
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bicalutamide as immediate therapy
Trial: 11109422
Drug: HCT/amiloride 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCT/amiloride 50 mg/5 mg
Trial: 9182081
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg oral flosequinan after 10 days of treatment
Trial: 30419911
Drug: Routine daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine daily care during radiotherapy treatment (Control)
Trial: 26453951
Drug: Comprehensive self-management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive self-management (CSM) program combining cognitive behavioral therapy with relaxation and dietary strategies; 9 sessions (1 hour each) over 13 weeks
Trial: 21780085
Drug: Aluminum chloride
RxNorm normalized name: Aluminum Chloride
DrugBank: Aluminum chloride (DB11081)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum chloride (20 mM) injections daily from E12 to E15
Trial: 21780085
Drug: Aluminum chloride
RxNorm normalized name: Aluminum Chloride
DrugBank: Aluminum chloride (DB11081)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum chloride (2 mM) injections daily from E12 to E15
Trial: 21433319
Drug: Prostamol Uno
RxNorm normalized name: unoprostone
DrugBank: Unoprostone (DB06826)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostamol Uno (PU) 320 mg/day for 36 months
Trial: 11206864
Drug: Rizatriptan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rizatriptan (10 mg)
Trial: 11061582
Drug: Zolmitriptan (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan (2.5 mg)
Trial: 1557928
Drug: Two-component pertussis
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-component pertussis vaccine (containing pertussis toxoid and filamentous haemagglutinin)
Trial: 29968397
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg baclofen
Trial: 26050104
Drug: Itolizumab 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itolizumab 0.2 mg/kg weekly with methotrexate
Trial: 26050104
Drug: Itolizumab 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itolizumab 0.4 mg/kg weekly with methotrexate
Trial: 26050104
Drug: Itolizumab 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itolizumab 0.8 mg/kg weekly with methotrexate
Trial: 20142538
Drug: Fixed-combination latanoprost-timolol
RxNorm normalized name: latanoprost / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-combination latanoprost-timolol (FCLT)
Trial: 17356043
Drug: Conventional GH
RxNorm normalized name: LINER,SECURELY YOURS,PAPER PAK #GH-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional GH dose of 40 microg/kg/d (n = 34)
Trial: 15699378
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg/day administered three times daily (TID)
Trial: 15699378
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg/day administered twice daily (BID)
Trial: 15699378
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg/day administered TID
Trial: 15699378
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg/day administered BID
Trial: 11889661
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg/night)
Trial: 11889661
Drug: Cyclobenzaprine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine (10 mg/night)
Trial: 7842192
Drug: No inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No inhaled corticosteroids (Control)
Trial: 2121114
Drug: Nitroglycerin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (5 mg intravenous infusion for 60 minutes)
Trial: 650201
Drug: Marijuana extract
RxNorm normalized name: marijuana pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana extract cookies (0.3 mg/kg delta‐9‐tetrahydrocannabinol)
Trial: 31566486
Drug: Concurrent laparoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP)
Trial: 21632099
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment (surgery and chemotherapy) for White patients
Trial: 21632099
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment (surgery and chemotherapy) for African-American patients
Trial: 21632099
Drug: Cytoreductive surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoreductive surgery and chemotherapy for both racial groups
Trial: 19081121
Drug: Ivermectin and
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin and albendazole combination (total of 400mg)
Trial: 16720865
Drug: Monomeric contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monomeric contrast agent
Trial: 16720865
Drug: Dimeric contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimeric contrast agent
Trial: 7731155
Drug: Both contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both contrast agents
Trial: 10890578
Drug: Cerivastatin 0.8
RxNorm normalized name: cerivastatin 0.8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.8 mg after an overnight fast (8 a.m. dosing)
Trial: 10890578
Drug: Cerivastatin 0.8
RxNorm normalized name: cerivastatin 0.8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.8 mg with a high-fat breakfast (8 a.m. dosing)
Trial: 10890578
Drug: Cerivastatin 0.8
RxNorm normalized name: cerivastatin 0.8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.8 mg with evening meal (6 p.m. dosing, low-fat)
Trial: 10890578
Drug: Cerivastatin 0.8
RxNorm normalized name: cerivastatin 0.8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.8 mg 4 hours after dinner (10 p.m. dosing)
Trial: 3158124
Drug: Kamillosan cream
RxNorm normalized name: Kamillosan
DrugBank: Levomenol (DB13153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Kamillosan cream
Trial: 31238925
Drug: Intra-articular steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular steroid (IAS) injections
Trial: 21810747
Drug: Intravenous mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mannitol (1.5 g/kg followed by 0.5 g/kg every 8 hours; n = 30)
Trial: 21810747
Drug: No adjunctive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjunctive therapy (n = 31)
Trial: 11525086
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with sulphonylurea derivatives or metformin
Trial: 9145887
Drug: Teicoplanin 6
RxNorm normalized name: teicoplanin 66.7 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 6 mg x kg(‐1) intravenously at induction of anesthesia
Trial: 9145887
Drug: Teicoplanin 12
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 12 mg x kg(‐1) intravenously at induction of anesthesia
Trial: 3129008
Drug: Captopril 12.5
RxNorm normalized name: captopril 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 12.5 mg three times daily for 14 days
Trial: 29844129
Drug: Binimetinib (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binimetinib (30 mg twice a day continuous or 45 mg twice a day intermittent) with intravenous weekly paclitaxel (80 mg/m2)
Trial: 29844129
Drug: Binimetinib (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binimetinib (45 mg twice a day continuous)
Trial: 29844129
Drug: Binimetinib (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binimetinib (45 mg twice a day intermittent)
Trial: 16563917
Drug: Tolvaptan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (10 mg/day, increased to 60 mg/day as needed)
Trial: 16563917
Drug: Fluid restriction
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid restriction (1,200 ml/day) plus placebo
Trial: 12836579
Drug: Treatment mediation
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment mediation
Trial: 9052581
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of micronized 17 beta-estradiol (1 mg, 0.5 mg, 0.25 mg)
Trial: 9052581
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of micronized 17 beta-estradiol (1 mg, 0.5 mg)
Trial: 20560941
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration
Trial: 8336809
Drug: Intra-arterial mannitol
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial mannitol infusion (group A)
Trial: 8336809
Drug: No intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: No intra-arterial mannitol infusion (group B)
Trial: 27304433
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg basimglurant MR
Trial: 27304433
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg basimglurant MR
Trial: 23547081
Drug: Gemcitabine (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1,000 mg/m² on days 1, 8, and 15 of a 28-day cycle)
Trial: 23547081
Drug: S-1 (80,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 (80, 100, or 120 mg/d according to body-surface area on days 1 through 28 of a 42-day cycle)
Trial: 23547081
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus S-1 (gemcitabine 1,000 mg/m² on days 1 and 8 plus S-1 60, 80, or 100 mg/d according to body-surface area on days 1 through 14 of a 21-day cycle)
Trial: 12601627
Drug: Daily multivitamin
RxNorm normalized name: DAILY MULTIVITAMIN TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multivitamin therapy including 1 mg of folic acid for 4 weeks
Trial: 12601627
Drug: Supplementation with
RxNorm normalized name: Similac For Supplementation with Iron Powder for Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementation with 1 mg vitamin B(12) for an additional 4 weeks
Trial: 12601627
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin therapy (folic acid and vitamin B(12))
Trial: 7832258
Drug: Paper diapers
RxNorm normalized name: Vanicream Diaper Rash
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paper diapers containing absorbent gel material
Trial: 90218
Drug: Prednisone 5
RxNorm normalized name: prednisone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 5 mg three times a day for 3-12 months
Trial: 90218
Drug: Methylprednisolone 96
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 96 mg/day for 7 days
Trial: 22743678
Drug: Tralokinumab (150,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tralokinumab (150, 300 or 600 mg)
Trial: 20824270
Drug: Dronabinol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (10 mg QID)
Trial: 16009860
Drug: Parenteral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral anticoagulant agent or warfarin
Trial: 16009860
Drug: Unfractionated or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractionated or low‐molecular‐weight heparin
Trial: 16009860
Drug: Bridge therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bridge therapy (injectable anticoagulant agent plus warfarin)
Trial: 10709504
Drug: Treatment-resistant periodontitis
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-resistant periodontitis patients
Trial: 10709504
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with severe marginal periodontitis who had responded to treatment
Trial: 30860858
Drug: Asthma controller
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma controller medication adherence
Trial: 17458427
Drug: Physician instruction
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician instruction to use controller medication intermittently
Trial: 17458427
Drug: Desire for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desire for control over treatment
Trial: 11411906
Drug: 0.1% isotretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% isotretinoin cream with chemical sunscreens
Trial: 11411906
Drug: 4% benzoyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% benzoyl peroxide cream
Trial: 1211587
Drug: Topical analgesia
RxNorm normalized name: ANALGESIC TOP GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical analgesia using lignocaine applied to the pyriform fossae for superior laryngeal nerve block and topical analgesia of larynx and trachea.
Trial: 31760855
Drug: Traditional six-month
RxNorm normalized name: moth bean extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional six-month follow-up programme with monthly calls (CON)
Trial: 29673620
Drug: Acetaminophen 1000mg
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 1000mg
Trial: 28177706
Drug: BCAA (0.087
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA (0.087 g/kg body mass)
Trial: 16540962
Drug: Povidone-iodine group
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine group (20 mL of a 10% povidone-iodine aqueous solution rinsing)
Trial: 16540962
Drug: Saline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group (60 mL of saline solution rinsing)
Trial: 10856105
Drug: Low-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose interferon alfa-2b (LDI) for 2 years
Trial: 6142252
Drug: Towne strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Towne strain cytomegalovirus (CMV) vaccine
Trial: 28094472
Drug: Single-hormone artificial
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-hormone artificial pancreas
Trial: 28094472
Drug: Dual-hormone artificial
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dual-hormone artificial pancreas
Trial: 24853314
Drug: Wound infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound infiltration (WI) with 1 mg·kg(‐1) 0.25% bupivacaine
Trial: 24853314
Drug: Ultrasound-guided rectus
RxNorm normalized name: Sus scrofa rectum preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided rectus sheath block (USGRSB) with 0.5 mg·kg(‐1) 0.25% bupivacaine per side
Trial: 22832531
Drug: Fortified balanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified balanced salt solution (BSS Plus)
Trial: 9806648
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose chemoradiotherapy with 5-fluorouracil (5-FU) and mitomycin
Trial: 9806648
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose chemoradiotherapy with 5-FU and mitomycin
Trial: 7659873
Drug: Sodium bicarbonate‐trometamol‐phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate‐trometamol‐phosphate mixture (250 ml with buffering capacity 500 mmol/l)